Funder
Pfizer
National Comprehensive Cancer Network
Reference20 articles.
1. Recognizing and addressing challenges to the adoption of trastuzumab biosimilars and;Whalen;Am J Manag Care,2020
2. Biosimilars in oncology in the United States: a review;Nabhan;JAMA Oncol,2018
3. The role of biosimilars in value-based oncology care;Patel;Cancer Manag Res,2018
4. Oncology biosimilars: New developments and future directions;Bachu;Cancer Rep (Hoboken),2022
5. Delivering affordable cancer care in high-income countries;Sullivan;Lancet Oncol,2011